Art

J-GLOBAL ID：201602207983959114   Reference number：16A0186127

TNF receptor type 2 transmits caspase-dependent apoptotic signals in fibroblast-like synoviocytes derived from theumatoid arthritis

TNF受容体タイプ2は関節リウマチ由来の線維芽細胞様滑膜細胞においてカスパーゼ依存性アポトーシスシグナルを伝達する

Author (4)： HIRANO Hiroyasu (Kawasaki Medical School, Kurashiki, JPN) ,  IGARASHI Hideya (Kawasaki Medical School, Kurashiki, JPN) ,  MORITA Yoshitaka (Kawasaki Medical School, Kurashiki, JPN) ,  ISHIHARA Katsuhiko (Kawasaki Medical School, Kurashiki, JPN)
Material： Kawasaki Medical Journal  (Kawasaki Med J)
Volume： 41  Issue： 2  Page： 29-40  Publication year： 2015 
JST Material Number： F1413A  ISSN： 0385-0234  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *rheumatoid arthritis ,...
Semi thesaurus term： MH7A cell ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0186127&from=J-GLOBAL&jstjournalNo=F1413A") }}

JST classification (1)： Basic medicine on musculoskeletal system  (GG01020B)

Reference (28)：

• Bottini N, Firestein GS: Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 9: 24-33, 2013
• Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 423: 356-361, 2003
• Lipsky PE, van der Heijde DM, St Clair EW, et al.: Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343: 1594-1602, 2000
• van der Heijde D, Klareskog L, Rodriguez-Valverde V, et al.: Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 54: 1063-1074, 2006
• Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT: The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54: 26-37, 2006

Terms in the title (8)： TNF受容体 ,  タイプ ,  関節リウマチ ,  線維芽細胞様滑膜細胞 ,  カスパーゼ ,  依存性 ,  アポトーシス ,  シグナル